Benefits
DashboardNot registered yet? Get a free account.
Sign UpNot registered yet? Get a free account.
Sign Up
You're about to leave our website and go to an external link. Are you sure?
The company manufactures pharmaceutical products for various therapeutic diseases
Macleods Pharmaceuticals Ltd, is an unlisted public company incorporated on 05 June, 1989. It is classified as a public limited company and is located in Mumbai, Maharashtra. It's authorized share capital is INR 65.00 cr and the total paid-up capital is INR 64.87 cr.
Read more
Buy Dashboard using Credits
This action will use 1 of your credits. Are you sure you want to go ahead?
Credits Balance:
0
** All rupee values in INR crores. Based on March 2023 numbers.
4.7%
-8.19%
26.4%
27.47%
62.87%
24.65%
0.23
-2.57
3.0
-0.18
-10.91
0.01
Buy Report or Plans
Company dashboard
Five year financials and ratios
Risk analysis
Interactive charts
All financials
All annual returns
MoA and AoA
Latest financials
Latest annual return
MoA and AoA
Five year financials and ratios
Shareholding and group structure
Litigation and more
Everything in financial report
Peers and financials
* GST not included
** Reports & MCA filings will be based on the latest available financials.
India
(55)
| State | Type | Address |
|---|
Locations on Map
Filter (4)
Severe Risk
Moderate Risk
Low Risk
Read more
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|---|
| Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Networth | |||||
| Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|---|
| Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|---|
| Sales + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Sales growth % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Expenses + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cost of goods | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Employee cost | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other costs | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other income | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Interest | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Depreciation | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Exceptional items | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Profit before tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Profit - disc. ops | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|---|
| Solvency + | |||||
| Total Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Debt/Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Assets/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Liquidity + | |||||
| Current Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Quick Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Interest Coverage | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Performance | |||||
| Gross Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Return + | |||||
| Return on Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Pre-tax ROCE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Return on Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Pre-tax ROIC | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Efficiency + | |||||
| Days Payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days Inventory | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days Receivable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Working Capital | |||||
| Cash Conversion Cycle | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Working Capital Days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
State Bank of India
No. of Loans: 1
Total Amount : 299.7 cr
Standard Chartered Bank
No. of Loans: 1
Total Amount : 71.5 cr
HDFC Bank Limited
No. of Loans: 1
Total Amount : 59.9 cr
Axis Bank Limited
No. of Loans: 1
Total Amount : 50.0 cr
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Managing Director | Banwarilal Murlidhar Bawri
Shareholder
|
00017795 | 36 years |
| Director | Girdharilal Murlidhar Bawri
Shareholder
|
00034197 | 35 years |
| Managing Director | Rajendra Murlidhar Agarwal
Shareholder
|
00034224 | 36 years |
| Director | Vinita Mayur Danait | 00216529 | 3 years |
| Director | Mihir Bipin Shah | 07586469 | 8 years |
| Director | Arvind Sadashiv Mokashi | 09305967 | 3 years |
| CEO | Vijay Girdharilal Agarwal
Shareholder
|
<HIDDEN> | 3 years |
| CS | Siddhesh Mahadeo Rane | <HIDDEN> | 6 years |
| Name | Status | Paid up Capital | Common Directors | Address |
|---|---|---|---|---|
| EAST AND WEST CLOTHING PRIVATE LIMITED |
Active
|
15.0 L | 2 | Maharashtra |
| AGARWAL HOLDINGS PRIVATE LIMITED |
Active
|
20.0 Cr | 4 | Maharashtra |
| MACLEODS LABORATORIES PRIVATE LIMITED |
Active
|
1.2 L | 2 | Maharashtra |
| KALYANKRIT INDUSTRIES PRIVATE LIMITED |
Active
|
50.0 L | 3 | Maharashtra |
| AGARWAL HOLDINGS PRIVATE LIMITED |
Active
|
20.0 Cr | 4 | Maharashtra |
| RATNIDEVI MURLIDHAR BAWRI SOCIAL WELFARE FOUNDATION |
Active
|
1.0 L | 2 | Maharashtra |
| KAN CONSULTANCY SOLUTIONS PRIVATE LIMITED |
Strike Off
|
7.5 L | 1 | Maharashtra |
| PMEA SOLAR SYSTEMS PRIVATE LIMITED |
Active
|
10.5 Cr | 1 | Maharashtra |
| INDIA DEBT RESOLUTION COMPANY LIMITED |
Active
|
20.0 Cr | 1 | Maharashtra |
| CREDIT WISE CAPITAL PRIVATE LIMITED |
Active
|
76.2 Cr | 1 | Maharashtra |
| SURYA LAKSHMI COTTON MILLS LTD |
Active
|
25.8 Cr | 1 | Telangana |
| TERRACIS DIGITAL LIMITED |
Active
|
11.2 Cr | 1 | Maharashtra |
| Name | State / Country | Incorporation Year | Paidup Capital |
|---|---|---|---|
| Macleods Pharma Espana S L U, Spain | Spain | - | - |
| Macleods Pharmaceuticals, LLC, Ukraine | Ukraine | - | - |
| Macleods Pharmaceuticals SA (Pty.) Ltd., South Africa | South Africa | - | - |
| Macleods Pharma USA INC., USA | United States | - | - |
| Macleods Pharma UK Ltd., UK | United Kingdom | - | - |
| Makmed LLC | Russian Federation | - | - |
| Oxus Pharma Ltd | Nigeria | - | - |
| Macleods Pharmaceuticals Philippines,inc | Philippines | - | - |
| Macleods Pharmaceuticals SDN BHD | Malaysia | - | - |
| Macleods Pharmaceuticals Philippines inc | Philippines | - | - |
The incorporation date of MACLEODS PHARMACEUTICALS LTD is 05 June, 1989
The authorized share capital of MACLEODS PHARMACEUTICALS LTD is INR ₹ 65.0 Cr.
The paid-up capital of MACLEODS PHARMACEUTICALS LTD is INR ₹ 64.9 Cr.
The registered address of MACLEODS PHARMACEUTICALS LTD is 304, ATLANTA ARCADE, MAROL CHURCH ROAD, ANDHERI (EAST) NA MUMBAI Maharashtra - 400059
The CIN number of MACLEODS PHARMACEUTICALS LTD is U24239MH1989PLC052049.
Expand
Delete
Collapse
See
details
